Refractory schizophrenia and atypical antipsychotics

  title={Refractory schizophrenia and atypical antipsychotics},
  author={D. Taylor and D. Duncan-McConnell},
  journal={Journal of Psychopharmacology},
  pages={409 - 418}
  • D. Taylor, D. Taylor, D. Duncan-McConnell
  • Published 2000
  • Medicine, Psychology
  • Journal of Psychopharmacology
  • Treatment resistant or refractory schizophrenia is a difficult to define condition of largely unknown prevalence. For 10 years, clozapine has been the standard treatment in this condition and is recognized unequivocally as being effective. However, clozapine is sometimes poorly tolerated and has the potential for severe toxicity. Partly as a result of this, other atypicals have recently been evaluated as treatments for refractory schizophrenia. In order to evaluate the evidence base relating to… CONTINUE READING

    Topics from this paper.

    Management of treatment resistance in schizophrenia
    • 274
    Clozapine resistance: Augmentation strategies
    • 114
    Treatment-Resistant Schizophrenia.
    • 96
    Treatment-resistant schizophrenia.
    • 124
    • PDF
    Restarting Clozapine after Neutropenia
    • 49


    Publications referenced by this paper.
    Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.
    • 3,475
    • Highly Influential
    • PDF
    Treatment-resistant schizophrenia--the role of clozapine.
    • 323
    • Highly Influential
    Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.
    • 357
    Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison.
    • 339
    Newer atypical antipsychotic medication versus clozapine for schizophrenia.
    • 100